Anagrelide Hcl

   
Google
 
Web NewDrugInformation.com

Anagrelide Hcl


Drug - Anagrelide Hcl
The trade name of the product as shown on the labeling.

Dosage - CAPSULE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Anagrelide Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - EQ 0.5MG BASE
The potency of the active ingredient(s), Anagrelide Hydrochloride. May repeat for multiple part products.

Applicant - BARR
The firm name holding legal responsibility for Anagrelide Hcl. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 076530
The FDA assigned number to Anagrelide Hcl. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Anagrelide Hcl. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Apr 18, 2005
The date Anagrelide Hcl was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Anagrelide Hcl. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Anagrelide Hcl is in. Format is RX, OTC, DISCN.

Applicant Full Name - Barr Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Anagrelide Hcl.

Anagrelide Hcl